Project partners

DECIDER is a multidisciplinary research project bringing together expertize from 16 research groups and companies in 14 organizations located in 7 European countries, in order to develop diagnostic tools and improve the treatment options for high-grade serous ovarian cancer. The expertise of the partners ranges from clinical medicine, genomics, molecular biology, computer science and Artificial Intelligence all the way to biomedical and privacy laws.

For the partner descriptions, click on the logos below.

2cureX A/S
Aiforia Technologies Oy
Barcelona Supercomputing Center
Danish Cancer Society
Heidelberg University Hospital
Hospital District of Southwest Finland logo
Helsinki University Hospital
Institut Pasteur
Institute for Research in Biomedicine
Karolinska Institutet
University of Modena and Reggio Emilia